UK:
GMO Regulations In Europe Are "Not Fit For Purpose"
To print this article, all you need is to be registered or login on Mondaq.com.
"If the law is no good, then you have to go somewhere
else"
Julian Hitchcock, from our Life Sciences Regulatory team,
highlighted the need for a public-facing inquiry at a European
level that permits an analysis of what the law needs to do. He also
said that with the early 2018 decision by Michal Bobek, Advocate
General of the Court of Justice of the European Union, the
directive ironically exempts from regulation those organisms
produced by an entirely random process, but it regulates those
which are actually produced by a very precise process.
You can read the full article on Labiotech.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from UK
AI In Drug Discovery
J A Kemp LLP
Developing new or more effective drugs for treating medical conditions can revolutionise care, and drug discovery is a huge part of the business of pharmaceutical companies.
News Analysis: Health And Social Care Act 2022
1 Chancery Lane
In 2019 NHS England and NHS Improvement (NHSEI) were asked to identify any changes, including changes to legislation, that would help it deliver the ambitions in the NHS Long Term Plan.
Lessons From The Cambridge Peregrines
Marks & Clerk
It is not just students who are drawn to the colleges of Cambridge. Those with an eagle eye might also be able to spot the city's resident pair of mating peregrine falcons.
FemTech – A Market On The Rise
Goodwin Procter LLP
2021 was a banner year for the women's health and wellness industry as global venture capital investment in FemTech companies surpassed $1B for the first time.